Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shareholders of Dr. Reddy's Laboratories have approved the re-appointment of Mr. G V Prasad (DIN: 00057433) as Whole-Time Director designated as Co-Chairman and Managing Director at the 41st AGM held on July 24, 2025. The re-appointment is for a 5-year term, effective from January 30, 2026 to January 29, 2031. The Board had earlier recommended this at its meeting on May 9, 2025. Mr. Prasad is one of the company's promoters with 36+ years of pharmaceutical industry leadership experience and is brother-in-law of Chairman Mr. K Satish Reddy.
Continuity at the top leadership level with an existing promoter-family director, which provides stability but keeps the senior management within the founding family. This is a procedural re-appointment, not a change, so limited direct impact on the stock is expected.